Articles On ImpediMed (ASX:IPD)

  ImpediMed (ASX:IPD) are the first top 5 national payor covering SOZO testing for cancer patients at risk for lymphoedema. In response, CEO and MD Richard Valencia said, ”Cigna’s policy provides access to coverage for all individuals at ri...

19 Jul 2023 - A snapshot of the stocks on the move, featuring ImpediMed (ASX:IPD), Imugene Limited (ASX:IMU) and Brightstar Resources (ASX:BTR).

Weekly update on stockbroker recommendation, target price, and earnings forecast changes. By Mark Woodruff Guide: The FNArena database tabulates the views of eight major Australian and international stockbrokers: Citi, Bell Potter, Macquari...

World Overnight SPI Overnight 7182.00 – 37.00 – 0.51% S&P ASX 200 7253.20 – 25.80 – 0.35% S&P500 4446.82 – 8.77 – 0.20% Nasdaq Comp 13791.65 – 25.12 – 0.18% DJIA 34288.64 – 129.83 – 0.38% S&P500 VIX 14.18 + 0.48 3....

World Overnight SPI Overnight 7233.00 – 12.00 – 0.17% S&P ASX 200 7279.00 + 32.90 0.45% S&P500 4455.59 Nasdaq Comp 13816.77 DJIA 34418.47 S&P500 VIX 13.70 US 10-year yield 3.86 USD Index 103.08 + 0.09...

World Overnight SPI Overnight 7216.00 – 1.00 – 0.01% S&P ASX 200 7246.10 + 42.80 0.59% S&P500 4455.59 + 5.21 0.12% Nasdaq Comp 13816.77 + 28.85 0.21% DJIA 34418.47 + 10.87 0.03% S&P500 VIX 13.57 – 0.02 – 0.15% US...

Clinical validation study confirms efficacy of INOVIQ’s SubB2M/CA15-3 test for breast cancer Ramsay releases several announcements this week including possible sale of joint Asian venture Mach 7 expects significant cash collections in Q4...

ShareCafeMiners surge on higher iron ore prices: ASX closes up 1% by Peter Milios   At the closing bell, the S&P/ASX 200 was 1.00 per cent higher at 7,216.30. The increase was driven by the mining and consumer discretionary sectors, whi...

ShareCafeAustralia’s inventories increase for March Qtr: ASX 1.05% higher at noon by Peter Milios   In the March quarter, Australia’s inventories increased by 1.2 per cent compared to the previous quarter, surpassing Bloomberg’s predicted 0...

ShareCafeStocks of the Hour: REZ, WA1, IPD                    Resources & Energy Group (ASX:REZ) announced that their opening drilling campaign has confirmed nickel sulphides at their Springfield Nickel Prospect in WA. MD and CEO,...

05 Jun 2023 - A snapshot of the stocks on the move featuring Resources & Energy Group (ASX:REZ), WA1 Resources (ASX:WA1) and ImpediMed (ASX:IPD).

ASX health stocks outperforming the broader market but remain flattish for week Several ASX health plays undertaking capital raising with more expected in H2 CY23 Micro-X successfully tests its Argus bomb detection unit opening door to US$...

The market shows that biotechs are making a gradual comeback in 2023 What are some of the catalysts that will push this momentum further? ASX biotechs that announced FDA breakthroughs this year   After a challenging 2022, we are finally s...

ASX health stocks have fallen in the past five days in line with broader markets Volpara Health Technologies reports strong FY23 results, above Morgan’s expectations Pharmaxis reports positive trial results in potential breakthrough treatm...

EBR announces positive results of its pivotal SOLVE-CRT trial at Heart Rhythm 2023 in US EBR latest ASX biotech company to achieve a key catalyst, opening door to US$2.5 billion market Company now working on regulatory and commercialisatio...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week on a positive note. At the time of writing, the benchmark index is up 0.6% to 7,278.9 points. Four ASX shares that have failed to follow the market high...

S&P/ASX 200 closes up 0.40%, while the emerging companies index rises 0.43% Algerian mining regulator issues a mining permit for Terramin’s Tala Hamza zinc-lead project Retail component of Next DC’s entitlement offer opens and is expec...

The Brisbane-headquartered medtech is drumming up interest in a $20 million placement, cashing in on the changes to cancer care guidelines in the US.

ASX health stocks rise in the past five days outperforming broader markets Avita Medical product sales up 40% on pcp to US$10.5 million in Q1 FY23 Proteomics International Laboratories inks a deal with Sonic Healthcare USA Healthcare and...

ShareCafeASX closes 0.4% higher as US futures rise by Peter Milios   The S&P/ASX 200 index finished 0.4 per cent higher at 7,220 points as a result of the rise in US futures due to Apple’s better-than-expected results. This gain in the...

ASX health stocks fall 0.8% in the past five days in line with broader markets following latest rate hike Investors rewarding health stocks with near term catalysts in 2023, including Neuren and Impedimed Health imaging stock Volpara recor...

ShareCafeResults from Macquarie & ANZ: ASX 0.11% higher by Peter Milios   At noon, the S&P/ASX 200 is 0.11 per cent higher at 7,200.80. Macquarie Group (ASX:MQG) reported a record profit of $5.18 billion for the year ending March 31...

ShareCafeStocks of the Hour: SPT, IPD, MGT                    Splitit Payments (ASX:SPT, OTCQX:SPTTY), announces it has signed a new two-year partnership agreement with Visa. Through this collaboration, participating acquirers and mer...

05 May 2023 - A snapshot of the stocks on the move featuring Splitit Payments (ASX:SPT), ImpediMed Limited (ASX:IPD) and Magnetite Mines (ASX:MGT).

ImpediMed gets clearance from the US FDA for its SOZO Pro bioimpedance spectroscopy SOZO Pro offers a new, higher standing weight capacity compared to SOZO Incannex’s subsidiary to open a clinic to provide psychedelic-assisted psychotherap...

The ASX is set to extend losses on banking crisis concerns Shares in regional banks PacWest and Western Alliance collapsed The ECB raised its key rate by 25bp   The ASX is poised to extend its losses on Friday following another selloff in...

The ASX is expected to fall on Friday on further fears surrounding the global banking sector — US bank stocks continue to tumble, dragging Wall Street down. Here are some ASX-listed companies to look out for on Friday: Splitit Payment...

ASX closes 5 points lower, down 0.08% after a day of ups and downs Goldies are the clear winners again, up 1.96% and well ahead of the market Mt Monger does well with a 23% gain to be over +130% for the month   After an early grimace-indu...

ASX health stocks rise 0.97% in the past five days in line with broader markets Impedimed up 99% after BIS tech named in latest US NCCN guidelines for lymphoedema  EBR Systems to release top line results at cardiac conference Heart Rhythm...

ShareCafeASX closes flat despite rise in US futures by Peter Milios   At the closing bell, the S&P/ASX 200 was 0.10 per cent higher at 6,962, and closed almost unchanged despite a rise in US futures. The index ended up 0.1 per cent at 6...

The ASX saw a shaky rally on Monday, mimicking US futures. The ASX 200 gained 6.8 points to 6962. An Australian bank boss has warned the nation to brace for higher banking costs and a potential financial crisis. ANZ Chief Executive Sh...

Benchmark set to finish close to flat as Energy stocks slump again Goldies are surging again, with that sector up 1.3% for the day Even the big banks are bracing for trouble with talk of a crisis getting louder by the day   After a modera...

The Impedimed Limited (ASX: IPD) share price has had a sensational start to the week. In afternoon trade, the ASX biotech share is up 86% to 11 cents. Why is this ASX biotech share rocketing higher? Investors have been buying this ASX biot...

Impedimed (IPD) shares soar on Monday after the US National Comprehensive Cancer Network (NCCN) recommends regular screenings with bioimpedance spectroscopy This marks the first time the NCCN’s Clinical Practice Guidelines in Oncology fo...

ShareCafeEnergy only sector lagging: ASX up 0.27% at noon by Peter Milios   At noon, the S&P/ASX 200 is 0.27 per cent higher at 6,974.10, with all sectors rising except for Energy. The early boost was attributed to US futures rising 0.6...

This content is created by Smallcaps Authors. [Author : Imelda Cotton] A screening platform developed by ImpediMed (ASX: IPD) for the assessment of lymphoedema is expected to increase its profile with the announcement that bioimpedance sp...

ImpediMed surges as the US NCCN included bioimpedance spectroscopy (BIS) as part new guidelines ImpediMed has the only FDA-cleared BIS technology for the assessment of lymphoedema GTG adds 3 new diseases to its geneType Multi-Test   Imped...

ShareCafeStocks of the Hour: IPD, ALO, GBR                    ImpediMed (ASX:IPD) announced that the National Comprehensive Cancer Network® (NCCN®) released a new version of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guid...

27 Mar 2023 - A snapshot of the stocks on the move featuring ImpediMed (ASX:IPD), Alloggio Group (ASX:ALO) and Great Boulder Resources (ASX:GBR).

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX health stocks fall 1.87% in the past five days as reporting season ends Healius moves to a statutory loss of ~$29 million following reduced demand for Covid-19 testing Catalysts in next few months for several ASX health stocks which co...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ALG)) - Ardent Leisure ((ASB)) - Austal ((AFG)) - Australian Finance Group ((AVH)) - Avita Medical ((BRI)) - Big River Industries ((SQ2)) - Block ((BXB)) - Brambles ((CB...

These three S&P/ASX All Ords (ASX: XAO) shares are having a mixed day on the market after the release of their latest results today. Helia Group is the standout of these ASX All Ords shares after the company announced a big lift in ea...

ASX health stocks rise 2.27% this week after finishing up 3.9% in January in strong start to 2023 Mach 7 posts a record quarter in sales after landing its largest ever contract in December EBR System’s pivotal trial into WiSE on schedule,...

ShareCafeIron ore surge not enough to lift the ASX: Aus shares close 0.16% lower by Peter Milios   Iron ore prices have reached a seven-month high due to increased demand expectations from China after its reopening following a Covid-19 surg...

ShareCafeASX down 0.15% at noon despite spike in US markets by Peter Milios   The global race for lithium, a commodity crucial for the electric vehicle (EV) industry, has intensified as German Chancellor Olaf Scholz signed an agreement with...

ImpediMed (IPD) appoints Richard Valencia as its Managing Director and CEO, effective December 1Current interim CEO David Anderson will continue to support the company to help ensure a smooth transition of leadershipMr Valencia has 30 years...

Sonic has taken a stake in Microba Immutep enters into second deal with Merck (Germany) and Pfizer  ImpediMed has a new CEO   Sonic takes strategic stake in Microba Giant healthcare stock Sonic Healthcare (ASX:SHL) has bought a stake in s...

ShareCafeASX ignores prospect of further COVID restrictions in China, closes 0.59% higher by Peter Milios   China has reported its first COVID death in six months, sparking up the likelihood of harsher lockdowns. Interestingly, the ASX has...

ShareCafeEyes await the new BNPL laws: ASX up 0.57% at noon by Peter Milios   The Treasury is expected to release a discussion paper today on the BNPL sector. The paper is likely to outline that Australia’s current buy now, pay later provid...